Effects of Spray and Stretch on Postneedling Soreness and Sensitivity After Dry Needling of a Latent Myofascial Trigger Point.

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
CEU San Pablo University
ClinicalTrials.gov Identifier:
NCT01608633
First received: May 27, 2012
Last updated: September 3, 2013
Last verified: September 2013
  Purpose

Pain after dry needling or injection in the muscle is a frequent secondary effect in the treatment of myofascial pain syndrome. In this trial spray and stretch technique is evaluated as a method to reduce this soreness. As well, the characteristics and the different factors that influence in this pain will be described.


Condition Intervention Phase
Pain After Dry Needling
Other: Spray and stretch
Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single Blind (Investigator)
Primary Purpose: Treatment

Further study details as provided by CEU San Pablo University:

Primary Outcome Measures:
  • Pain [ Time Frame: 72 hours ] [ Designated as safety issue: No ]
    Visual analogue scale


Secondary Outcome Measures:
  • Pain [ Time Frame: 48 hours ] [ Designated as safety issue: No ]
    Pressure pain threshold

  • Psychological factors [ Time Frame: 72 hours after needling ] [ Designated as safety issue: No ]
    Symptom check list revised. SCL-90-r


Enrollment: 70
Study Start Date: March 2012
Primary Completion Date: April 2013 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Spray and stretch Other: Spray and stretch
Physiotherapeutic technique which consist in stretching the muscle while a cold spray is applied on the skin.
No Intervention: Control

  Eligibility

Ages Eligible for Study:   18 Years to 65 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Subjects presenting latent trigger points in the trapezius muscle

Exclusion Criteria:

  • Subjects with active trigger points or absence of trigger points.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01608633

Locations
Spain
CEU San Pablo University
Madrid, Spain, 28668
Sponsors and Collaborators
CEU San Pablo University
  More Information

No publications provided

Responsible Party: CEU San Pablo University
ClinicalTrials.gov Identifier: NCT01608633     History of Changes
Other Study ID Numbers: CEU-001
Study First Received: May 27, 2012
Last Updated: September 3, 2013
Health Authority: Spain: Ethics Committee

ClinicalTrials.gov processed this record on September 18, 2014